Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Ka K, Schiappa R, Terlizzi M, Mallet F, Martin E, Chand ME, Demogeot N, Peiffert D, Pommier P, Quivrin M, Kissel M, Pasquier C, Khalifa J, Bossi A, Hannoun-Levi JM, Blanchard P. Ka K, et al. Radiother Oncol. 2023 Mar;180:109460. doi: 10.1016/j.radonc.2022.109460. Epub 2023 Jan 10. Radiother Oncol. 2023. PMID: 36638842
In Regard to Frankart et al.
Laurent PA, Ka K, Gachot B, de Kerangal Q, Descols P, Brau JJ, Blanchard P, Benmoussa N. Laurent PA, et al. Among authors: ka k. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):582-584. doi: 10.1016/j.ijrobp.2021.06.005. Int J Radiat Oncol Biol Phys. 2021. PMID: 34473983 No abstract available.
Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot.
Sun R, Achkar S, Ammari S, Bockel S, Gallois E, Bayle A, Battistella E, Salviat F, Merad M, Laville A, Ka K, Griscelli F, Albiges L, Barlesi F, Bossi A, Rivera S, Chargari C, Deutsch E. Sun R, et al. Among authors: ka k. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):947-956. doi: 10.1016/j.ijrobp.2021.02.022. Epub 2021 Feb 17. Int J Radiat Oncol Biol Phys. 2021. PMID: 33609591 Free PMC article.
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy.
Sun R, Lerousseau M, Briend-Diop J, Routier E, Roy S, Henry T, Ka K, Jiang R, Temar N, Carré A, Laville A, Hamaoui A, Laurent PA, Rouyar A, Robert C, Robert C, Deutsch E. Sun R, et al. Among authors: ka k. J Immunother Cancer. 2022 Oct;10(10):e004867. doi: 10.1136/jitc-2022-004867. J Immunother Cancer. 2022. PMID: 36307149 Free PMC article.
89 results